Displaying 11–20 of 558 results
Feb 2, 2021 Eye On the Cure Research News
Researchers believe the VLC-PUFAs may benefit people with autosomal dominant Stargardt disease, AMD, and possibly other retinal degenerations
Jan 29, 2021 The Foundation in the News
Development of lead asset SPVN06 to further benefit from high-level Clinical Advisory Board
Jan 28, 2021 Eye On the Cure Research News
The company plans to enroll additional patients as young as four years old
Jan 26, 2021 Eye On the Cure Research News
Company will seek marketing approval for the emerging therapy
Jan 26, 2021 Press Releases
In honor of Rare Disease Day, this February 28th virtual event will raise awareness and fund research leading to treatments and cures for blinding retinal diseases.
Jan 25, 2021 Beacon Stories
Jenny was diagnosed with retinitis pigmentosa (RP), just like her mom, at the age of 34. In her own words, Jenny shares her experience with being diagnosed with RP and her journey to accepting it with hopefulness.
Jan 13, 2021 Eye On the Cure Research News
Company also announced progress in enrollment for Phase 1 / 2 clinical trials for emerging USH2A and RHO RNA therapies.
Jan 11, 2021 Beacon Stories
26-year-old Becca is a two-time Paralympic swimmer for Team USA, diagnosed with Usher syndrome type 1 (USH1) at only four years old. But she has never let her diagnosis with Usher syndrome stop her from doing exactly what she puts her mind to.
Jan 7, 2021 Eye On the Cure Research News
In a Phase ½ clinical trial, the emerging treatment reduced the burden of regular anti-VEGF injections
The Foundation’s Strategic Council is a group of young professionals with an affinity to the Fighting Blindness mission and represent the next generation of Foundation leaders.